2023-2029 Global Regorafenib API Industry Research & Trends Analysis Report

According to YH Research, the global market for Regorafenib API should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Regorafenib API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Regorafenib API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Purity≥99% segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Tablets has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Regorafenib API include MSN Laboratories Pvt Ltd, Hetero Labs Ltd, Shandong Anhong Pharmaceutical, Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical and Xinxiang SL Pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Regorafenib API. Report Highlights:
(1) Global Regorafenib API market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Regorafenib API market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Regorafenib API market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Regorafenib API segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Regorafenib API segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Regorafenib API, capacity, production and trends.
(7) Regorafenib API industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Purity≥99%
Purity<99%
Market segment by application, can be divided into
Tablets
Others
Market segment by players, this report covers
MSN Laboratories Pvt Ltd
Hetero Labs Ltd
Shandong Anhong Pharmaceutical
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical
Xinxiang SL Pharmaceutical